The analysis of patients with AIE in different antibody subgroups, however, revealed that patients with AIE associated with anti-NMDAR antibodies had the lowest prevalence of dystonia or other movement disorders, autonomic disturbances and endocrine disturbances, while patients with AIE associated with anti-LG1(+CASPR2) antibodies had the highest prevalence. Here, CNTNAP2 is linked to movement disorder.